General MedicationsORALGeneric
MINOLIRA
MINOCYCLINE HYDROCHLORIDE
Standard Dose
EQ 105MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview MINOLIRA is listed in Drugs@FDA under application 209269 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient MINOCYCLINE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 105MG BASE Sponsor EPI HLTH Submission history Latest submission status date: 2017-05-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview MINOLIRA is listed in Drugs@FDA under application 209269 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MINOCYCLINE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 105MG BASE Sponsor EPI HLTH Submission history Latest submission status date: 2017-05-08 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.